Sharon Nahm (@sharonnahm) 's Twitter Profile
Sharon Nahm

@sharonnahm

Medical oncologist in Sydney, Australia.
PhD candidate - Thinking and Talking about Prognosis in Advanced cancer.

ID: 985386466195877888

calendar_today15-04-2018 05:16:55

63 Tweet

185 Followers

199 Following

Sharon Nahm (@sharonnahm) 's Twitter Profile Photo

Excited to be a part of #ACORD21 this year and eager to learn from a diverse group of faculty and participants! moga.org.au/acord-workshop

Milita Zaheed (@militazaheed) 's Twitter Profile Photo

Don't forget to register your interest with COSA to get an Asia Pacific focused Global Oncology group going. A place for PallCare, RadOnc, MedOnc, all Oncs and Allied Health wanting to improve outcome in our region. ausyoungoncs Palliative Care Australia RANZCR Rad Oncology #APROSIG

Don't forget to register your interest with <a href="/COSAoncology/">COSA</a> to get an Asia Pacific focused Global Oncology group going. A place for PallCare, RadOnc, MedOnc, all Oncs and Allied Health wanting to improve outcome in our region. <a href="/ausyoungoncs/">ausyoungoncs</a> <a href="/Pall_Care_Aus/">Palliative Care Australia</a> <a href="/FacRadOncology/">RANZCR Rad Oncology</a> #APROSIG
Sharon Nahm (@sharonnahm) 's Twitter Profile Photo

>25% of ppl receiving ICIs had an emergency presentation and 1 in 3 were due to IRAEs. 40% had previous >G2 IRAEs and 29% required 2L immunosuppression. Excited to share real-world data from The Christie NHS published in the The European Journal of Cancer. authors.elsevier.com/a/1eamd3QE--RV…

The Christie Institute for Cancer Education (@cicemanchester) 's Twitter Profile Photo

Join us on 28th June for our #SoOMelanoma2022 study day. Using professional expertise & patient perspectives, we look holistically at early interventions & and the current clinical trials in place. Book now: bit.ly/37waPqm

Join us on 28th June for our #SoOMelanoma2022 study day. Using professional expertise &amp; patient perspectives, we look holistically at early interventions &amp; and the current clinical trials in place.
 
Book now: bit.ly/37waPqm
The Christie Institute for Cancer Education (@cicemanchester) 's Twitter Profile Photo

The 28th June sees us explore Melanoma, with our professional speakers. With only a FEW DAYS LEFT to secure your place, book your ticket now and don’t miss out. You can join us LIVE or ON-DEMAND to watch back at your convenience. 💻 bit.ly/37aDS2x #SoOMelanoma2022

Sharon Nahm (@sharonnahm) 's Twitter Profile Photo

Was great to see the familiar faces of old colleagues again! Thanks for inviting me to speak at the #SoOMelanoma2022 study day today.

Was great to see the familiar faces of old colleagues again! Thanks for inviting me to speak at the #SoOMelanoma2022 study day today.
COSA (@cosaoncology) 's Twitter Profile Photo

It's not too late to register for tonight's free, online multidisciplinary conversation about ageism in cancer #COSAageism ➡️ bit.ly/cosa-ageism-fo… ⬅️ (While you're there, register for next week too!) #GeriOnc #Ageism

It's not too late to register for tonight's free, online multidisciplinary conversation about ageism in cancer #COSAageism

➡️ bit.ly/cosa-ageism-fo… ⬅️ 
(While you're there, register for next week too!)

#GeriOnc #Ageism
Judith Trotman (@judithtrotman1) 's Twitter Profile Photo

Fabulous to be back at Grand Rounds FTT again with Martin Stockler helping us estimate 3 survival scenarios for patients with advanced cancer. CTC.USYD.edu.au/3scenarios/ Prunella Blinman

Fabulous to be back at Grand Rounds FTT again with Martin Stockler helping us estimate 3 survival scenarios for patients with advanced cancer. CTC.USYD.edu.au/3scenarios/ <a href="/drprunellab/">Prunella Blinman</a>
Bishal Gyawali, MD, PhD, FASCO (@oncology_bg) 's Twitter Profile Photo

Hot off the press in NatureRevClinOncol ! Using examples from trials presented at #ASCO23, in this educational piece, I highlight how we should think about crossover in cancer clinical trials. Such education also forms a core theme of what we do Common Sense Oncology. In this piece, I argue

Hot off the press in <a href="/NatRevClinOncol/">NatureRevClinOncol</a> ! Using examples from trials presented at #ASCO23, in this educational piece, I highlight how we should think about crossover in cancer clinical trials. Such education also forms a core theme of what we do <a href="/csoncol/">Common Sense Oncology</a>.
In this piece, I argue
JNCI (@jnci_now) 's Twitter Profile Photo

Study finds oncologists are no more likely to overestimate survival time than to underestimate it. Simple multiples of EST provide well-calibrated estimates of worst-case, typical, and best-case scenarios for survival: oxford.ly/4e9hyUQ @martinstockler

Sharon Nahm (@sharonnahm) 's Twitter Profile Photo

Encouraging all MOGA members to register for this interesting webinar on 'Conflicts of Interest in Medical Oncology'. (Also eligible to contribute to the new RACP mandatory CPD requirements on ethics and professional behaviour) moga.org.au/conflicts-of-i…

Sharon Nahm (@sharonnahm) 's Twitter Profile Photo

Only 3 days left to register for this webinar! Learn about "Conflicts of Interest in Medical Oncology" and participate in Q&A whilst logging in CPD points 👍🏻 moga.org.au/conflicts-of-i…

Sharon Nahm (@sharonnahm) 's Twitter Profile Photo

How do oncologists balance maintaining hope & truth-telling? When & how should they challenge unrealistic hope? Less than 1 wk to go for this MOGA Medical Ethics Webinar. Participants can log CPD points for ethics & professional behaviour. Register today! moga.org.au/medical-ethics…